New Ray Medicine International Holding Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG647461117
HKD
0.24
-0.01 (-2.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'15
Mar'15
Dec'14
Sep'14
Jun'14
Mar'14
Dec'13
Net Sales
75.02
54.96
65.54
53.52
59.00
28.87
66.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
75.02
54.96
65.54
53.52
59.00
28.87
66.96
Raw Material Cost
52.20
38.16
45.21
38.00
42.66
19.88
44.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.20
Selling and Distribution Expenses
10.49
5.48
5.34
4.35
5.82
3.76
3.88
Other Expenses
0.00
0.00
0.00
0.00
0.00
0.00
-0.02
Total Expenditure (Excl Depreciation)
62.69
43.64
50.55
42.35
48.47
23.65
48.19
Operating Profit (PBDIT) excl Other Income
12.3
11.299999999999999
15
11.200000000000001
10.5
5.2
18.799999999999997
Other Income
1.29
0.44
0.28
0.58
0.92
0.17
0.29
Operating Profit (PBDIT)
13.63
11.77
15.26
11.75
11.76
5.40
19.06
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.20
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
22.83
16.81
20.33
15.52
16.34
8.99
22.66
Depreciation
0.00
0.00
0.00
0.00
0.31
0.00
0.00
Profit Before Tax
13.63
11.77
15.26
11.75
11.45
5.40
18.86
Tax
5.69
4.05
4.70
3.72
4.07
1.69
5.26
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7.93
7.71
10.56
8.03
7.38
3.70
13.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7.93
7.71
10.56
8.03
7.38
3.70
13.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7.93
7.71
10.56
8.03
7.38
3.70
13.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.01
0.01
0.01
0.0
0.01
Reserves
437.45
0.00
303.19
0.00
200.87
0.00
213.20
Earnings per share (EPS)
0.33
0.37
0.56
0.46
0.43
0.21
0.96
Diluted Earnings per share
0.33
0.37
0.56
0.46
0.43
0.21
0.96
Operating Profit Margin (Excl OI)
16.44%
20.61%
22.87%
20.87%
17.84%
18.1%
28.04%
Gross Profit Margin
18.16%
21.41%
23.29%
21.96%
19.93%
18.69%
28.16%
PAT Margin
10.57%
14.03%
16.11%
15.01%
12.51%
12.83%
20.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2015 is 27.12% vs -29.51% in Jun 2014

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2015 is 6.76% vs 393.33% in Jun 2014

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2015 is 13.89% vs -25.00% in Jun 2014

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2015 has fallen from Jun 2014

Compare Quarterly Results Of New Ray Medicine International Holding Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
75.02
0
75.02
Other Operating Income
0.00
0.00
0.00
Total Operating income
75.02
0
75.02
Raw Material Cost
52.20
0
52.20
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
10.49
0
10.49
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
62.69
0
62.69
Operating Profit (PBDIT) excl Other Income
12.34
0.00
12.34
Other Income
1.29
0
1.29
Operating Profit (PBDIT)
13.63
0
13.63
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
22.83
0
22.83
Depreciation
0.00
0
0.00
Profit Before Tax
13.63
0
13.63
Tax
5.69
0
5.69
Provisions and contingencies
0.00
0
0.00
Profit After Tax
7.93
0
7.93
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7.93
0
7.93
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7.93
0
7.93
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
437.45
0
437.45
Earnings per share (EPS)
0.33
0
0.33
Diluted Earnings per share
0.33
0
0.33
Operating Profit Margin (Excl OI)
16.44%
0%
0.00
16.44%
Gross Profit Margin
18.16%
0%
0.00
18.16%
PAT Margin
10.57%
0%
0.00
10.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.50 Million
in Jun 2015

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2015 is 36.36% vs -16.03% in Mar 2015

stock-summary

YoY Growth in quarter ended Jun 2015 is 27.12% vs -29.51% in Jun 2014

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.79 Million
in Jun 2015

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2015 is 2.60% vs -27.36% in Mar 2015

stock-summary

YoY Growth in quarter ended Jun 2015 is 6.76% vs 393.33% in Jun 2014

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.23 Million
in Jun 2015

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2015 is 8.85% vs -24.67% in Mar 2015

stock-summary

YoY Growth in quarter ended Jun 2015 is 13.89% vs -25.00% in Jun 2014

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.44%
in Jun 2015

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2015 has fallen from Mar 2015

stock-summary

YoY Growth in quarter ended Jun 2015 has fallen from Jun 2014